Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.
Other companies in Allogene Therapeutics’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Larimar Therapeutics Inc (NASDAQ:LRMR), Palisade Bio Inc (NASDAQ:PALI), AC Immune SA (NASDAQ:ACIU) and Eupraxia Pharmaceuticals Inc (NASDAQ:EPRX).
Allogene Therapeutics has a consensus price target of $10.54.
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $1.5 last updated December 15, 2025 at 9:09 AM EST.
There are no upcoming dividends for Allogene Therapeutics.
Allogene Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Allogene Therapeutics.
Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.